Tempus AI Cash on Hand 2023-2025 | TEM

Tempus AI cash on hand from 2023 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Tempus AI cash on hand for the quarter ending March 31, 2025 was $0.219B, a 130.55% increase year-over-year.
  • Tempus AI cash on hand for 2024 was $0.448B, a 126.88% increase from 2023.
  • Tempus AI cash on hand for 2023 was $0.198B, a 34.78% decline from 2022.
  • Tempus AI cash on hand for 2022 was $0.303B, a 0% decline from .
Tempus AI Annual Cash on Hand
(Millions of US $)
2024 $448
2023 $198
2022 $303
Tempus AI Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $219
2024-12-31 $448
2024-09-30 $466
2024-06-30 $490
2024-03-31 $95
2023-12-31 $198
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $303
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.010B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Hims & Hers Health (HIMS) United States $11.646B 121.00
Doximity (DOCS) United States $11.561B 53.52
IRhythm Technologies (IRTC) United States $4.435B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.739B 0.00
Privia Health (PRVA) United States $2.547B 174.08
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.642B 0.00
Schrodinger (SDGR) United States $1.551B 0.00
10x Genomics (TXG) United States $1.535B 0.00
Clover Health Investments (CLOV) United States $1.527B 0.00
Azenta (AZTA) United States $1.475B 68.57
Evolent Health (EVH) United States $1.334B 113.60
Omnicell (OMCL) United States $1.291B 22.78
Claritev (CTEV) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.582B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.450B 0.00
Talkspace (TALK) United States $0.430B 128.50
Outset Medical (OM) United States $0.333B 0.00
TruBridge (TBRG) United States $0.329B 731.00
Health Catalyst (HCAT) United States $0.269B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
Zepp Health (ZEPP) Netherlands $0.139B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.091B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00